crRNA targeting DNMT1 locus. Related to Figure 2B. (B) Dose-dependent inhibitory effects of ps42DNA on AsCpf1-mediated genome editing at the DNMT1 locus in 293T cells. ps42DNA-DNMT1 was added at 5 h after treatment with CRISPR-Cpf1 mRNA and crRNA targeting DNMT1 locus. Related to Figure 2C .
(C) Time-dependent inhibitory effects of ps42DNA-AAVS1 on AsCpf1-mediated genome editing at the AAVS1 locus in 293T cells. ps42DNA-AAVS1 was added at various time points after treatment with AsCpf1 mRNA and crRNA targeting AAVS1 locus. Related to Figure 2D .
(D) Time-dependent inhibitory effects of ps42DNA-FANCF on AsCpf1-mediated genome editing at the FANCF locus in 293T cells. ps42DNA-FANCF was added at various time points after treatment with AsCpf1 mRNA and crRNA targeting FANCF locus. Related to Figure 2E .
(E) Time-dependent inhibitory effects of ps42DNA on AsCpf1-mediated genome editing at the DNMT1 locus in Hep3B cells. ps42DNA-DNMT1 was added at various time points after treatment with AsCpf1 mRNA and crRNA targeting DNMT1 locus. Related to Figure 2F . (F) Quantification of DNA substrate remaining (%) in the presence of AsCpf1 protein, crRNA and ps42DNA (or RAMpsDNA). The uncleaved DNA substrate was quantified by densitometric analysis and normalized to the DNA substrate alone group. Data are expressed as the mean ± SD from three biological replicates (NS, not significant; two-tailed t-test).
Gels in (A) and (B) were resolved on 15% non-denaturing TBE polyacrylamide gels and stained by SYBR Gold.
Gels in (C)-(E) were separated on 2% agarose gels and stained by EZ-Vision In-Gel staining. The green and red arrowheads denote the intact DNA substrate and cleaved DNA fragments, respectively. Table S1 . crRNAs and oligonucleotides used in this study. Related to Figures 1-5.
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